Polarean Imaging Share Discussion Threads

[fuji99] 15/10/2020 11:09

Following home work and a bit of research on the impact of POLX technology worldwide, this is what convinced me we are dealing with a revolution in lung imaging and diagnostics, by eliminating radiations dangers: "Polarean Imaging plc (AIM: POLX), the medical--imaging technology company, with an investigational drug--device combination product for magnetic resonance imaging (MRI), announces its submission of a New Drug Application ("NDA") and request for priority review to the US Food and Drug Administration ("FDA") for hyperpolarised (129) Xenon gas used to evaluate pulmonary function and to visualise the lung using MRI."

[fuji99] 15/10/2020 09:26

I expected some profit taking today and took the opportunity to buy. I am convinced the company has a unique and very useful medical technology that will thrive in every hospital in the world. In addition, it will definitely support Covid pulmonary detection instead of using X-ray, especially in vulnerable people.

[74tom] 14/10/2020 15:28

I agree with the Maxcyte comparison - wanted to buy it at £1.80 but Barclays didn't have it listed and my HL account was tied up in other shares. Saw it rising and thought, nah I'm not buying as the rise is too fast...next thing you know it's £3! Now £4.35 and still rising.

Happily I've now made the same mistake here, entirely feasible it continues re-rating until it reaches £200m market cap if a big buyer wants in (with Amati holding just shy of 15% it must be on the radar's of other II's, see the top up from Tyndall last week...)

[fuji99] 14/10/2020 15:04

Let's hope so and wait to see what's happening this week.

[acuere] 14/10/2020 14:47

You would expect a retrace at some stage but I don’t think it will be much as there appears to be a lot of new interest. Again similar to how MAXC performed this year.

Also, there is a lot of potential good news in the short term.
Company flagged up that they expect more orders this year “We are in discussions with several potential customers and anticipate additional orders during calendar year 2020.”

And FDA will reply to fast track request by 6th December.

[fuji99] 14/10/2020 13:13

Usually we see it the next day, most of the time, as a result of profit taking.

[richardjohn10] 14/10/2020 12:53

Can't see a retrace yet mind, it's too strong.

[fuji99] 14/10/2020 12:51

It's up more than 50% in a just few days. I expect a retrace as nothing goes indefinitely up in a vertical line but this is an interesting company.

[acuere] 14/10/2020 10:39

Strongly advise people listen to discussion on Vox podcast from 28.50 about Polx. Would also suggest listen to interview with CEO last week. Also a couple of other discussions about them this month.

[acuere] 14/10/2020 10:18

This share reminds me of Maxcyte when it reached market cap of £100m. I already held and was looking to top up on any fall back. It never did pull back. So I eventually paid over £3 for shares I could have bought for less than £2 if I hadn’t been so greedy. Make no mistake this is likely to be £250m mkt cap long before FDA approval granted.

[the count] 14/10/2020 10:00

--->LOGLORRY1

Interesting.

Just checked the RSP for a size of 10k shares.

No MM wants to offer stock at, or inside the offer, yet all are prepared to bid over the bid price for stock.

So currently loking strong, but of course, that can all change in a matter of minutes, especially after such strong rises.

Regards,

THE COUNT!

[loglorry1] 14/10/2020 09:46

From a trading perspective the free float is very tightly held. Even a few small buys take this up several pence. Everyone in the stock will hold at least until FDA approval at which point big insti buyers will step in and clean up any lose stock anyway.

[loglorry1] 14/10/2020 09:44

Despite the run up the shares are still very cheap. Ask yourself what 100% of an FDA approved, patented world wide pulmanary imaging system is worth? They are the only people on the planet that have the technology to image lung function.

This is multi-billion pound IP.

[the count] 14/10/2020 09:29

--->ALL

Like what I see here.

Picked up an initial lot of 15,000 shares today for the road.

Good luck one and all.

Hopefully in for the very long term.

Regards,

THE COUNT!

[richardjohn10] 14/10/2020 09:27

You could be right kidda

[markstevenkirby80] 14/10/2020 09:23

Can't see this slowing down, this is driven on facts,

[richardjohn10] 13/10/2020 18:15

Been a great couple days, where will this settle ??

[markstevenkirby80] 13/10/2020 10:31

Nice to see

[74tom] 13/10/2020 10:10

NT for even £300 worth of shares right now...free float is diminishing rapidly here, could see a strong rise into the 60's if the buying pressure maintains (and it should given the laughable valuation).

[supernumerary] 12/10/2020 18:51

And if the machines are up and running safely and successfully in research establishments, why on earth would the FDA not also allow them in hospitals where they're needed for diagnostics?

Roll on the approval...

[acuere] 12/10/2020 18:47

Hopefully this won’t be the last new order of the year. This from the interims:-

“Researchers continue to apply for and receive grants to purchase our polariser systems. We are in discussions with several potential customers and anticipate additional orders during calendar year 2020.”

Whilst nothing is a certainty, if grants are being given to purchase Polx polariser system, you’d be hard pushed not to convert these discussions into orders.

[acuere] 12/10/2020 14:57

Correction to my earlier post.

Today’s RNS was a new order. So it’s 23 installations and 3 orders.

[acuere] 12/10/2020 12:04

Yep once it finally cracked that 50 it’s quickly headed to 60. Will that prove so stubborn?

[74tom] 12/10/2020 11:58

Seller at 50p has been taken to the cleaners here, that’s a very decisive breakout to all time highs :)

[acuere] 12/10/2020 11:41

From last years HY results :-

“ The number of systems installed or on order is currently 25*.”

Today’s order is number 24. So there is at least one other system installation still to come which I seem to recall they expect to complete before year end.

Clearly FDA approval will be catalyst to enable ramp up of sales.

Renx on my watchlist.